Publications:

---

Pharmacogenetics of hepatocellular carcinoma and cholangiocarcinoma.

Cancer Drug Resistance (Alhambra, Calif.)

Alonso-Peña, Marta M; Sanchez-Martin, Anabel A; Sanchon-Sanchez, Paula P; Soto-Muñiz, Meraris M; Espinosa-Escudero, Ricardo R; Marin, Jose J G JJG

Publication Date: 2019

Variant appearance in text: SLC22A1: Arg61Ser

PubMed Link: 35582588

Variant Present in the following documents:

• Main text
• cdr-2-680.pdf

View BVdb publication page

---

Genetic Heterogeneity, Therapeutic Hurdle Confronting Sorafenib and Immune Checkpoint Inhibitors in Hepatocellular Carcinoma.

Cancers

Atwa, Sara M SM; Odenthal, Margarete M; M El Tayebi, Hend H

Publication Date: 2021-08-27

Variant appearance in text: SLC22A1: R61S

PubMed Link: 34503153

Variant Present in the following documents:

• Main text
• cancers-13-04343.pdf

View BVdb publication page

---

Genetic Heterogeneity, Therapeutic Hurdle Confronting Sorafenib and Immune Checkpoint Inhibitors in Hepatocellular Carcinoma.

Cancers

Atwa, Sara M SM; Odenthal, Margarete M; El Tayebi, Hend M HM

Publication Date: 2021-08-27

Variant appearance in text: SLC22A1: R61S

PubMed Link: 34503153

Variant Present in the following documents:

• Main text
• cancers-13-04343.pdf

View BVdb publication page

---

Sorafenib Resistance in Hepatocellular Carcinoma: The Relevance of Genetic Heterogeneity.

Cancers

Cabral, Loraine Kay D LKD; Tiribelli, Claudio C; Sukowati, Caecilia H C CHC

Publication Date: 2020-06-15

Variant appearance in text: SLC22A1: R61S

PubMed Link: 32549224

Variant Present in the following documents:

• Main text
• cancers-12-01576.pdf

View BVdb publication page

---

Role of OCT1 in hepatocellular carcinoma.

Oncotargets And Therapy

Li, Jingguo J; Yang, Zhengyi Z; Tuo, Biguang B

Publication Date: 2019

Variant appearance in text: SLC22A1: R61S

PubMed Link: 31413596

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma.

World Journal Of Gastroenterology

De Mattia, Elena E; Cecchin, Erika E; Guardascione, Michela M; Foltran, Luisa L; Di Raimo, Tania T; Angelini, Francesco F; D'Andrea, Mario M; Toffoli, Giuseppe G

Publication Date: 2019-08-07

Variant appearance in text: SLC22A1: Arg61Ser

PubMed Link: 31413525

Variant Present in the following documents:

• Main text
• WJG-25-3870.pdf

View BVdb publication page

---

Genetic Heterogeneity of SLC22 Family of Transporters in Drug Disposition.

Journal Of Personalized Medicine

Lozano, Elisa E; Briz, Oscar O; Macias, Rocio I R RIR; Serrano, Maria A MA; Marin, Jose J G JJG; Herraez, Elisa E

Publication Date: 2018-04-16

Variant appearance in text: SLC22A1: R61S

PubMed Link: 29659532

Variant Present in the following documents:

• Main text
• jpm-08-00014.pdf

View BVdb publication page

---

The lack of the organic cation transporter OCT1 at the plasma membrane of tumor cells precludes a positive response to sorafenib in patients with hepatocellular carcinoma.

Oncotarget

Geier, Andreas A; Macias, Rocio I R RI; Bettinger, Dominik D; Weiss, Johannes J; Bantel, Heike H; Jahn, Daniel D; Al-Abdulla, Ruba R; Marin, Jose J G JJ

Publication Date: 2017-02-28

Variant appearance in text: SLC22A1: R61S

PubMed Link: 28178663

Variant Present in the following documents:

• Main text
• oncotarget-08-15846.pdf

View BVdb publication page

---

Role of the plasma membrane transporter of organic cations OCT1 and its genetic variants in modern liver pharmacology.

Biomed Research International

Lozano, Elisa E; Herraez, Elisa E; Briz, Oscar O; Robledo, Virginia S VS; Hernandez-Iglesias, Jorge J; Gonzalez-Hernandez, Ana A; Marin, Jose J G JJ

Publication Date: 2013

Variant appearance in text: SLC22A1: R61S

PubMed Link: 23984399

Variant Present in the following documents:

• Main text
• BMRI2013-692071.pdf

View BVdb publication page

---